Oxomemazine/guaifenesin
Jump to navigation
Jump to search
Combination of | |
---|---|
Oxomemazine | H1 receptor antagonist (antihistamine) |
Guaifenesin | expectorant |
Clinical data | |
Trade names | Toplexil and others |
Routes of administration | Oral |
ATC code |
|
Identifiers | |
CAS Number |
Oxomemazine/guaifenesin is a sedative antihistamine plus expectorant.[1][2] It is a combination of oxomemazine and guaifenesin.
It is sold under a variety of brand names including Toplexil by Aventis. It is sold over the counter in France, Morocco, Egypt, Algeria, South Korea and the UAE[citation needed]. The oxomemazine ingredient (antihistamine) is not approved by the U.S. Food and Drug Administration (FDA), either for over the counter or prescription use. It is sold in France as cough syrup. French travelers also use it as a sleeping aid for long flights.[citation needed]
References
- ^ Oxomemazine, drugs.com
- ^ Toplexil, drugs.com
Categories:
- Articles with short description
- Short description matches Wikidata
- Drugs not assigned an ATC code
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Drugs that are a combination of chemicals
- All articles with unsourced statements
- Articles with unsourced statements from March 2019
- Articles with unsourced statements from December 2015
- Combination drugs
- H1 receptor antagonists
- Sanofi
- Sedatives
- All stub articles
- Pharmacology stubs